Quarterly report pursuant to Section 13 or 15(d)

Convertible, Redeemable Preferred Stock, Stock Options, Common Stock and Warrants (Tables)

v2.4.0.8
Convertible, Redeemable Preferred Stock, Stock Options, Common Stock and Warrants (Tables)
9 Months Ended
Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Convertible, Redeemable Preferred Stock
The following is a summary of activity of Row 44's convertible, redeemable preferred stock for the nine months ended September 30, 2013 (in thousands):

Row 44 Preferred Stock
Series A-1
Series A-2
Series B-1
Series B-2
Series C-1
Series C-2
Total
Balance - January 1, 2013
$
9,245

$
21,454

$
27,488

$
19,981

$
24,535

$
19,837

$
122,540

Cumulative dividends
60

139

179

129

170

141

818

Accretion of preferred stock




57

67

124

Conversion to common stock
(9,305
)
(21,593
)
(27,667
)
(20,110
)
(24,762
)
(20,045
)
(123,482
)
Balance - September 30, 2013
$

$

$

$

$

$

$


Common Stock

The following is a summary of activity of the Company's common stock for the nine months ended September 30, 2013 (in thousands):

GEE Common Stock
Common Stock
Amount
Common Non-Voting Stock
Amount
Balance - January 1, 2013
20,352

$
2


$

Recapitalized as a result of Row 44 Merger

15,373

2

4,750

1

Stock Purchase of AIA



14,368

1

Repurchased and retired common stock held by certain executives
(95)




Asset Purchase of PMG
431




Balance - September 30, 2013
36,061

$
4

19,118

$
2

Schedule of Stock Options, Valuation Assumptions
Fair values of the stock options were determined using the Black-Scholes model and the following level 3 assumptions:

Expected life (in years)
4.87

Risk-free interest rate
0.77
%
Expected stock volatility
50.00
%
Expected dividend yield
0.00
%
Schedule of Share-based Compensation, Stock Options, Activity
Stock option activity for nine months ended September 30, 2013 is as follows:

Row 44 2011 Equity Incentive Plan
Shares
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (in years)
Aggregate Intrinsic Value
Outstanding at January 1, 2013
43,686,492

$
0.11

7.95
$
9,187

Granted



Exercised-cashless (Global Eagle)
(40,644,825
)
0.11


Exercised-cash
(225,000
)
0.10


Forfeited
(2,816,667
)
0.10


Outstanding - January 31, 2013

$

$


Global Eagle Stock Option Plan
Shares
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (in years)
Aggregate Intrinsic Value
Outstanding at January 31, 2013

$

$

Granted
5,270,000

9.82

4.44
149,500

Exercised



Forfeited
(500,000
)
9.79

4.43

Outstanding at September 30, 2013
4,770,000

9.82

4.44
149,500

Exercisable at September 30, 2013
93,750

9.40

2.56

Expected to vest at September 30, 2013
4,676,250

$
9.83

4.48
$
149,500

Schedule of Share-based Compensation, Stock Options, by Exercise Price Range
The following is a summary of the Company's stock options outstanding at September 30, 2013:

Exercise Price
Number Outstanding
Weighted Average Remaining Contractual Term (in years)
Number Exercisable
Weighted Average Exercise Price
$
10.00

2,970,000

4.34
43,750

$
10.00

$
9.83

700,000

4.74


$
9.79

525,000

4.43


$
8.88

575,000

4.62
50,000

8.88

 
4,770,000

4.44
93,750

$
9.40

Schedule of Share-based Compensation Expense Allocation
Stock-based compensation expense related to all employee and non-employee stock-based awards was as follows for the three and nine months ended September 30, 2013 and 2012 (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2013
2012
 
2013
2012
Stock-based compensation expense:
 
 
 
 
 
Cost of services
$

$

 
$

$

Sales and marketing expenses


 


Product development


 

32

General and administrative
526

73

 
1,902

716

Total stock-based compensation expense
$
526

$
73

 
$
1,902

$
748

Schedule of Share-based Compensation, Warrants, by Exercise Price Range
The following is a summary of all Row 44 warrants converted to warrants to purchase GEE common stock (exercise price per warrant and number of warrants presented using the conversion ratio to Global Eagle common stock used in the Row 44 Merger) outstanding at September 30, 2013:

Weighted Average Exercise Price per Warrant (as converted)
Number of Warrants (as converted)
Weighted Average Remaining Life (in years)
Common stock warrants
$
9.45

721,600

3.37
Series C Preferred stock warrants
$
8.74

734,451

3.69
The following is a summary of all Global Eagle warrants outstanding at September 30, 2013:

Exercise Price per Warrant
Number of Warrants
Class of Shares
Weighted Average Remaining Life (in years)
 
$
11.50

18,492,500

Public Warrants
4.34
Total outstanding
 
18,492,500

 
 
 
11.50

666,667

Sponsor Warrants
4.32
 
$
11.50

7,000,000

Sponsor Warrants
4.34
 Total outstanding
 
26,159,167

 
4.34
Row 44 Warrants
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Warrants, Activity
The following is a summary of activity for Row 44 warrants for common stock convertible into GEE common stock for the nine months ended September 30, 2013:

Row 44 Warrants for Common Stock - Upon Exercise Convertible to Global Eagle Common Stock
Number of Warrants
Weighted Average Exercise price
Weighted Average Remaining Contractual Term (in years)
Outstanding - January 1, 2013
84,612,107

$
0.0801

4.92
Granted
2,414,524



Exercised
(65,964,131)

0.0001


Forfeited



Outstanding - January 31, 2013
21,062,500

0.3214

4.03
Granted



Exercised



Forfeited



Outstanding - September 30, 2013
21,062,500

0.3214

3.37
Exercisable at September 30, 2013
21,062,500

0.3214

3.37
Global Eagle Acquisition Warrants
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Warrants, Activity
The following is a summary of Global Eagle warrants for the three and nine months ended September 30, 2013:

Global Eagle Warrants
Number of Warrants
Weighted Average Exercise price
Weighted Average Remaining Contractual Term (in years)
Outstanding at January 31, 2013
25,992,500

$
11.50

5.00
Granted
666,667

11.50


Exercised



Purchased
(500,000
)
11.50

 
Forfeited



Outstanding and exercisable at September 30, 2013
26,159,167

$
11.50

4.34